APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pre-Exposure Prophylaxis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pre-Exposure Prophylaxis Market Analysis and Forecast 2026-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchPre-Exposure Prophylaxis Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Pre-Exposure Prophylaxis Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Pre-Exposure Prophylaxis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pre-Exposure Prophylaxis Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pre-Exposure Prophylaxis Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pre-Exposure Prophylaxis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pre-Exposure Prophylaxis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pre-Exposure Prophylaxis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pre-Exposure Prophylaxis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pre-Exposure Prophylaxis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pre-Exposure Prophylaxis include Gilead Sciences, Lupin, Strides Pharma Science and Teva Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pre-Exposure Prophylaxis, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pre-Exposure Prophylaxis, also provides the sales of main regions and countries. Of the upcoming market potential for Pre-Exposure Prophylaxis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pre-Exposure Prophylaxis sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pre-Exposure Prophylaxis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pre-Exposure Prophylaxis sales, projected growth trends, production technology, application and end-user industry.

Pre-Exposure Prophylaxis Segment by Company

Gilead Sciences

Lupin

Strides Pharma Science

Teva Pharmaceuticals

Pre-Exposure Prophylaxis Segment by Type

Truvada

Discovy

Pre-Exposure Prophylaxis Segment by Application

Adult

Adolescent

Pre-Exposure Prophylaxis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Exposure Prophylaxis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pre-Exposure Prophylaxis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Exposure Prophylaxis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pre-Exposure Prophylaxis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pre-Exposure Prophylaxis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pre-Exposure Prophylaxis sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Truvada Major Manufacturers Table 3. Discovy Major Manufacturers Table 4. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Major Manufacturers Table 6. Adolescent Major Manufacturers Table 7. Pre-Exposure Prophylaxis Industry Trends Table 8. Pre-Exposure Prophylaxis Industry Drivers Table 9. Pre-Exposure Prophylaxis Industry Opportunities and Challenges Table 10. Pre-Exposure Prophylaxis Industry Restraints Table 11. Global Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Pre-Exposure Prophylaxis Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Pre-Exposure Prophylaxis Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2021-2026) Table 15. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2027-2032) Table 16. Global Pre-Exposure Prophylaxis Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Pre-Exposure Prophylaxis Sales by Region (2021-2026) & (K Units) Table 18. Global Pre-Exposure Prophylaxis Sales by Region (2027-2032) & (K Units) Table 19. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2021-2026) Table 20. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2027-2032) Table 21. Global Pre-Exposure Prophylaxis Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Pre-Exposure Prophylaxis Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Pre-Exposure Prophylaxis Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturers (2021-2026) Table 25. Global Pre-Exposure Prophylaxis Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Pre-Exposure Prophylaxis Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Pre-Exposure Prophylaxis Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Pre-Exposure Prophylaxis Manufacturers, Product Type & Application Table 29. Global Pre-Exposure Prophylaxis Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Pre-Exposure Prophylaxis by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Pre-Exposure Prophylaxis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pre-Exposure Prophylaxis Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Pre-Exposure Prophylaxis Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2021-2026) Table 36. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2027-2032) Table 37. Global Pre-Exposure Prophylaxis Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units) Table 39. Global Pre-Exposure Prophylaxis Sales by Type (2027-2032) & (K Units) Table 40. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2021-2026) Table 41. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2027-2032) Table 42. Global Pre-Exposure Prophylaxis Price by Type (2021-2026) & (US$/Unit) Table 43. Global Pre-Exposure Prophylaxis Price by Type (2027-2032) & (US$/Unit) Table 44. Global Pre-Exposure Prophylaxis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Pre-Exposure Prophylaxis Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Pre-Exposure Prophylaxis Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2021-2026) Table 48. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2027-2032) Table 49. Global Pre-Exposure Prophylaxis Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units) Table 51. Global Pre-Exposure Prophylaxis Sales by Application (2027-2032) & (K Units) Table 52. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2021-2026) Table 53. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2027-2032) Table 54. Global Pre-Exposure Prophylaxis Price by Application (2021-2026) & (US$/Unit) Table 55. Global Pre-Exposure Prophylaxis Price by Application (2027-2032) & (US$/Unit) Table 56. Gilead Sciences Company Information Table 57. Gilead Sciences Business Overview Table 58. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Gilead Sciences Pre-Exposure Prophylaxis Product Portfolio Table 60. Gilead Sciences Recent Development Table 61. Lupin Company Information Table 62. Lupin Business Overview Table 63. Lupin Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Lupin Pre-Exposure Prophylaxis Product Portfolio Table 65. Lupin Recent Development Table 66. Strides Pharma Science Company Information Table 67. Strides Pharma Science Business Overview Table 68. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolio Table 70. Strides Pharma Science Recent Development Table 71. Teva Pharmaceuticals Company Information Table 72. Teva Pharmaceuticals Business Overview Table 73. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolio Table 75. Teva Pharmaceuticals Recent Development Table 76. North America Pre-Exposure Prophylaxis Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Pre-Exposure Prophylaxis Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units) Table 79. North America Pre-Exposure Prophylaxis Sales by Type (2027-2032) & (K Units) Table 80. North America Pre-Exposure Prophylaxis Sales Price by Type (2021-2026) & (US$/Unit) Table 81. North America Pre-Exposure Prophylaxis Sales Price by Type (2027-2032) & (US$/Unit) Table 82. North America Pre-Exposure Prophylaxis Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Pre-Exposure Prophylaxis Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units) Table 85. North America Pre-Exposure Prophylaxis Sales by Application (2027-2032) & (K Units) Table 86. North America Pre-Exposure Prophylaxis Sales Price by Application (2021-2026) & (US$/Unit) Table 87. North America Pre-Exposure Prophylaxis Sales Price by Application (2027-2032) & (US$/Unit) Table 88. North America Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Pre-Exposure Prophylaxis Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 92. North America Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units) Table 93. North America Pre-Exposure Prophylaxis Sales by Country (2027-2032) & (K Units) Table 94. North America Pre-Exposure Prophylaxis Sales Price by Country (2021-2026) & (US$/Unit) Table 95. North America Pre-Exposure Prophylaxis Sales Price by Country (2027-2032) & (US$/Unit) Table 96. United States Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 97. Canada Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 98. Europe Pre-Exposure Prophylaxis Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Pre-Exposure Prophylaxis Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units) Table 101. Europe Pre-Exposure Prophylaxis Sales by Type (2027-2032) & (K Units) Table 102. Europe Pre-Exposure Prophylaxis Sales Price by Type (2021-2026) & (US$/Unit) Table 103. Europe Pre-Exposure Prophylaxis Sales Price by Type (2027-2032) & (US$/Unit) Table 104. Europe Pre-Exposure Prophylaxis Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Pre-Exposure Prophylaxis Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units) Table 107. Europe Pre-Exposure Prophylaxis Sales by Application (2027-2032) & (K Units) Table 108. Europe Pre-Exposure Prophylaxis Sales Price by Application (2021-2026) & (US$/Unit) Table 109. Europe Pre-Exposure Prophylaxis Sales Price by Application (2027-2032) & (US$/Unit) Table 110. Europe Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. Europe Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. Europe Pre-Exposure Prophylaxis Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. Europe Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units) Table 115. Europe Pre-Exposure Prophylaxis Sales by Country (2027-2032) & (K Units) Table 116. Europe Pre-Exposure Prophylaxis Sales Price by Country (2021-2026) & (US$/Unit) Table 117. Europe Pre-Exposure Prophylaxis Sales Price by Country (2027-2032) & (US$/Unit) Table 118. Germany Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 119. France Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 120. U.K. Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 121. Italy Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 122. Netherlands Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 123. China Pre-Exposure Prophylaxis Revenue by Type (2021-2026) & (US$ Million) Table 124. China Pre-Exposure Prophylaxis Revenue by Type (2027-2032) & (US$ Million) Table 125. China Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units) Table 126. China Pre-Exposure Prophylaxis Sales by Type (2027-2032) & (K Units) Table 127. China Pre-Exposure Prophylaxis Sales Price by Type (2021-2026) & (US$/Unit) Table 128. China Pre-Exposure Prophylaxis Sales Price by Type (2027-2032) & (US$/Unit) Table 129. China Pre-Exposure Prophylaxis Revenue by Application (2021-2026) & (US$ Million) Table 130. China Pre-Exposure Prophylaxis Revenue by Application (2027-2032) & (US$ Million) Table 131. China Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units) Table 132. China Pre-Exposure Prophylaxis Sales by Application (2027-2032) & (K Units) Table 133. China Pre-Exposure Prophylaxis Sales Price by Application (2021-2026) & (US$/Unit) Table 134. China Pre-Exposure Prophylaxis Sales Price by Application (2027-2032) & (US$/Unit) Table 135. Asia Pre-Exposure Prophylaxis Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Pre-Exposure Prophylaxis Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units) Table 138. Asia Pre-Exposure Prophylaxis Sales by Type (2027-2032) & (K Units) Table 139. Asia Pre-Exposure Prophylaxis Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Asia Pre-Exposure Prophylaxis Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Asia Pre-Exposure Prophylaxis Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Pre-Exposure Prophylaxis Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units) Table 144. Asia Pre-Exposure Prophylaxis Sales by Application (2027-2032) & (K Units) Table 145. Asia Pre-Exposure Prophylaxis Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Asia Pre-Exposure Prophylaxis Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Asia Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Asia Pre-Exposure Prophylaxis Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Asia Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units) Table 152. Asia Pre-Exposure Prophylaxis Sales by Country (2027-2032) & (K Units) Table 153. Asia Pre-Exposure Prophylaxis Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Asia Pre-Exposure Prophylaxis Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Japan Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 156. South Korea Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 157. India Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 158. Australia Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 159. China Taiwan Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 160. Southeast Asia Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 161. SAMEA Pre-Exposure Prophylaxis Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Pre-Exposure Prophylaxis Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units) Table 164. SAMEA Pre-Exposure Prophylaxis Sales by Type (2027-2032) & (K Units) Table 165. SAMEA Pre-Exposure Prophylaxis Sales Price by Type (2021-2026) & (US$/Unit) Table 166. SAMEA Pre-Exposure Prophylaxis Sales Price by Type (2027-2032) & (US$/Unit) Table 167. SAMEA Pre-Exposure Prophylaxis Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Pre-Exposure Prophylaxis Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units) Table 170. SAMEA Pre-Exposure Prophylaxis Sales by Application (2027-2032) & (K Units) Table 171. SAMEA Pre-Exposure Prophylaxis Sales Price by Application (2021-2026) & (US$/Unit) Table 172. SAMEA Pre-Exposure Prophylaxis Sales Price by Application (2027-2032) & (US$/Unit) Table 173. SAMEA Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. SAMEA Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. SAMEA Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. SAMEA Pre-Exposure Prophylaxis Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. SAMEA Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units) Table 178. SAMEA Pre-Exposure Prophylaxis Sales by Country (2027-2032) & (K Units) Table 179. SAMEA Pre-Exposure Prophylaxis Sales Price by Country (2021-2026) & (US$/Unit) Table 180. SAMEA Pre-Exposure Prophylaxis Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Brazil Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 182. Argentina Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 183. Chile Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 184. Colombia Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 185. Peru Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 186. Saudi Arabia Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 187. Israel Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 188. UAE Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 189. Turkey Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 190. Iran Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 191. Egypt Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Pre-Exposure Prophylaxis Distributors List Table 195. Pre-Exposure Prophylaxis Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Pre-Exposure Prophylaxis Image Figure 2. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pre-Exposure Prophylaxis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Truvada Image Figure 5. Discovy Image Figure 6. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pre-Exposure Prophylaxis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Image Figure 9. Adolescent Image Figure 10. Global Pre-Exposure Prophylaxis Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Figure 12. Global Pre-Exposure Prophylaxis Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Pre-Exposure Prophylaxis Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2021-2032) Figure 15. Global Pre-Exposure Prophylaxis Sales (2021-2032) & (K Units) Figure 16. Global Pre-Exposure Prophylaxis Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Pre-Exposure Prophylaxis Sales YoY (2021-2032) & (K Units) Figure 19. Europe Pre-Exposure Prophylaxis Sales YoY (2021-2032) & (K Units) Figure 20. China Pre-Exposure Prophylaxis Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Pre-Exposure Prophylaxis Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Pre-Exposure Prophylaxis Sales YoY (2021-2032) & (K Units) Figure 23. Global Pre-Exposure Prophylaxis Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Pre-Exposure Prophylaxis Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Pre-Exposure Prophylaxis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Pre-Exposure Prophylaxis Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2021-2032) Figure 29. Global Pre-Exposure Prophylaxis Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Pre-Exposure Prophylaxis Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2021-2032) Figure 32. Global Pre-Exposure Prophylaxis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Pre-Exposure Prophylaxis Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2021-2032) Figure 35. Global Pre-Exposure Prophylaxis Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Pre-Exposure Prophylaxis Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2021-2032) Figure 38. North America Pre-Exposure Prophylaxis Revenue Share by Type (2021-2032) Figure 39. North America Pre-Exposure Prophylaxis Sales Share by Type (2021-2032) Figure 40. North America Pre-Exposure Prophylaxis Revenue Share by Application (2021-2032) Figure 41. North America Pre-Exposure Prophylaxis Sales Share by Application (2021-2032) Figure 42. North America Pre-Exposure Prophylaxis Revenue Share by Country (2021-2032) Figure 43. North America Pre-Exposure Prophylaxis Sales Share by Country (2021-2032) Figure 44. Europe Pre-Exposure Prophylaxis Revenue Share by Type (2021-2032) Figure 45. Europe Pre-Exposure Prophylaxis Sales Share by Type (2021-2032) Figure 46. Europe Pre-Exposure Prophylaxis Revenue Share by Application (2021-2032) Figure 47. Europe Pre-Exposure Prophylaxis Sales Share by Application (2021-2032) Figure 48. Europe Pre-Exposure Prophylaxis Revenue Share by Country (2021-2032) Figure 49. Europe Pre-Exposure Prophylaxis Sales Share by Country (2021-2032) Figure 50. China Pre-Exposure Prophylaxis Revenue Share by Type (2021-2032) Figure 51. China Pre-Exposure Prophylaxis Sales Share by Type (2021-2032) Figure 52. China Pre-Exposure Prophylaxis Revenue Share by Application (2021-2032) Figure 53. China Pre-Exposure Prophylaxis Sales Share by Application (2021-2032) Figure 54. Asia Pre-Exposure Prophylaxis Revenue Share by Type (2021-2032) Figure 55. Asia Pre-Exposure Prophylaxis Sales Share by Type (2021-2032) Figure 56. Asia Pre-Exposure Prophylaxis Revenue Share by Application (2021-2032) Figure 57. Asia Pre-Exposure Prophylaxis Sales Share by Application (2021-2032) Figure 58. Asia Pre-Exposure Prophylaxis Revenue Share by Country (2021-2032) Figure 59. Asia Pre-Exposure Prophylaxis Sales Share by Country (2021-2032) Figure 60. SAMEA Pre-Exposure Prophylaxis Revenue Share by Type (2021-2032) Figure 61. SAMEA Pre-Exposure Prophylaxis Sales Share by Type (2021-2032) Figure 62. SAMEA Pre-Exposure Prophylaxis Revenue Share by Application (2021-2032) Figure 63. SAMEA Pre-Exposure Prophylaxis Sales Share by Application (2021-2032) Figure 64. SAMEA Pre-Exposure Prophylaxis Revenue Share by Country (2021-2032) Figure 65. SAMEA Pre-Exposure Prophylaxis Sales Share by Country (2021-2032) Figure 66. Pre-Exposure Prophylaxis Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pre-Exposure Prophylaxis Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Truvada
  • Discovy
Applications
  • Adult
  • Adolescent
Companies covered
  • Gilead Sciences
  • Lupin
  • Strides Pharma Science
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pre-Exposure Prophylaxis Market by Type
  3. 1.2.1 Global Pre-Exposure Prophylaxis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Truvada
  5. 1.2.3 Discovy
  6. 1.3 Pre-Exposure Prophylaxis Market by Application
  7. 1.3.1 Global Pre-Exposure Prophylaxis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult
  9. 1.3.3 Adolescent
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Pre-Exposure Prophylaxis Market Dynamics
  1. 2.1 Pre-Exposure Prophylaxis Industry Trends
  2. 2.2 Pre-Exposure Prophylaxis Industry Drivers
  3. 2.3 Pre-Exposure Prophylaxis Industry Opportunities and Challenges
  4. 2.4 Pre-Exposure Prophylaxis Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pre-Exposure Prophylaxis Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pre-Exposure Prophylaxis Revenue by Region
  3. 3.2.1 Global Pre-Exposure Prophylaxis Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pre-Exposure Prophylaxis Revenue by Region (2021-2026)
  5. 3.2.3 Global Pre-Exposure Prophylaxis Revenue by Region (2027-2032)
  6. 3.2.4 Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pre-Exposure Prophylaxis Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pre-Exposure Prophylaxis Sales by Region
  9. 3.4.1 Global Pre-Exposure Prophylaxis Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pre-Exposure Prophylaxis Sales by Region (2021-2026)
  11. 3.4.3 Global Pre-Exposure Prophylaxis Sales by Region (2027-2032)
  12. 3.4.4 Global Pre-Exposure Prophylaxis Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pre-Exposure Prophylaxis Revenue by Manufacturers
  2. 4.1.1 Global Pre-Exposure Prophylaxis Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pre-Exposure Prophylaxis Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pre-Exposure Prophylaxis Sales by Manufacturers
  6. 4.2.1 Global Pre-Exposure Prophylaxis Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pre-Exposure Prophylaxis Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pre-Exposure Prophylaxis Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pre-Exposure Prophylaxis Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pre-Exposure Prophylaxis Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pre-Exposure Prophylaxis Manufacturers, Product Type & Application
  13. 4.7 Global Pre-Exposure Prophylaxis Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pre-Exposure Prophylaxis Market CR5 and HHI
  16. 4.8.2 2025 Pre-Exposure Prophylaxis Tier 1, Tier 2, and Tier 3
5 Pre-Exposure Prophylaxis Market by Type
  1. 5.1 Global Pre-Exposure Prophylaxis Revenue by Type
  2. 5.1.1 Global Pre-Exposure Prophylaxis Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pre-Exposure Prophylaxis Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pre-Exposure Prophylaxis Sales by Type
  6. 5.2.1 Global Pre-Exposure Prophylaxis Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pre-Exposure Prophylaxis Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pre-Exposure Prophylaxis Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pre-Exposure Prophylaxis Price by Type
6 Pre-Exposure Prophylaxis Market by Application
  1. 6.1 Global Pre-Exposure Prophylaxis Revenue by Application
  2. 6.1.1 Global Pre-Exposure Prophylaxis Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pre-Exposure Prophylaxis Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pre-Exposure Prophylaxis Sales by Application
  6. 6.2.1 Global Pre-Exposure Prophylaxis Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pre-Exposure Prophylaxis Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pre-Exposure Prophylaxis Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pre-Exposure Prophylaxis Price by Application
7 Company Profiles
  1. 7.1 Gilead Sciences
  2. 7.1.1 Gilead Sciences Company Information
  3. 7.1.2 Gilead Sciences Business Overview
  4. 7.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Gilead Sciences Pre-Exposure Prophylaxis Product Portfolio
  6. 7.1.5 Gilead Sciences Recent Developments
  7. 7.2 Lupin
  8. 7.2.1 Lupin Company Information
  9. 7.2.2 Lupin Business Overview
  10. 7.2.3 Lupin Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Lupin Pre-Exposure Prophylaxis Product Portfolio
  12. 7.2.5 Lupin Recent Developments
  13. 7.3 Strides Pharma Science
  14. 7.3.1 Strides Pharma Science Company Information
  15. 7.3.2 Strides Pharma Science Business Overview
  16. 7.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolio
  18. 7.3.5 Strides Pharma Science Recent Developments
  19. 7.4 Teva Pharmaceuticals
  20. 7.4.1 Teva Pharmaceuticals Company Information
  21. 7.4.2 Teva Pharmaceuticals Business Overview
  22. 7.4.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolio
  24. 7.4.5 Teva Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Pre-Exposure Prophylaxis Market Size by Type
  2. 8.1.1 North America Pre-Exposure Prophylaxis Revenue by Type (2021-2032)
  3. 8.1.2 North America Pre-Exposure Prophylaxis Sales by Type (2021-2032)
  4. 8.1.3 North America Pre-Exposure Prophylaxis Price by Type (2021-2032)
  5. 8.2 North America Pre-Exposure Prophylaxis Market Size by Application
  6. 8.2.1 North America Pre-Exposure Prophylaxis Revenue by Application (2021-2032)
  7. 8.2.2 North America Pre-Exposure Prophylaxis Sales by Application (2021-2032)
  8. 8.2.3 North America Pre-Exposure Prophylaxis Price by Application (2021-2032)
  9. 8.3 North America Pre-Exposure Prophylaxis Market Size by Country
  10. 8.3.1 North America Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pre-Exposure Prophylaxis Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pre-Exposure Prophylaxis Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pre-Exposure Prophylaxis Market Size by Type
  2. 9.1.1 Europe Pre-Exposure Prophylaxis Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pre-Exposure Prophylaxis Sales by Type (2021-2032)
  4. 9.1.3 Europe Pre-Exposure Prophylaxis Price by Type (2021-2032)
  5. 9.2 Europe Pre-Exposure Prophylaxis Market Size by Application
  6. 9.2.1 Europe Pre-Exposure Prophylaxis Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pre-Exposure Prophylaxis Sales by Application (2021-2032)
  8. 9.2.3 Europe Pre-Exposure Prophylaxis Price by Application (2021-2032)
  9. 9.3 Europe Pre-Exposure Prophylaxis Market Size by Country
  10. 9.3.1 Europe Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pre-Exposure Prophylaxis Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pre-Exposure Prophylaxis Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Pre-Exposure Prophylaxis Market Size by Type
  2. 10.1.1 China Pre-Exposure Prophylaxis Revenue by Type (2021-2032)
  3. 10.1.2 China Pre-Exposure Prophylaxis Sales by Type (2021-2032)
  4. 10.1.3 China Pre-Exposure Prophylaxis Price by Type (2021-2032)
  5. 10.2 China Pre-Exposure Prophylaxis Market Size by Application
  6. 10.2.1 China Pre-Exposure Prophylaxis Revenue by Application (2021-2032)
  7. 10.2.2 China Pre-Exposure Prophylaxis Sales by Application (2021-2032)
  8. 10.2.3 China Pre-Exposure Prophylaxis Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pre-Exposure Prophylaxis Market Size by Type
  2. 11.1.1 Asia Pre-Exposure Prophylaxis Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pre-Exposure Prophylaxis Sales by Type (2021-2032)
  4. 11.1.3 Asia Pre-Exposure Prophylaxis Price by Type (2021-2032)
  5. 11.2 Asia Pre-Exposure Prophylaxis Market Size by Application
  6. 11.2.1 Asia Pre-Exposure Prophylaxis Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pre-Exposure Prophylaxis Sales by Application (2021-2032)
  8. 11.2.3 Asia Pre-Exposure Prophylaxis Price by Application (2021-2032)
  9. 11.3 Asia Pre-Exposure Prophylaxis Market Size by Country
  10. 11.3.1 Asia Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pre-Exposure Prophylaxis Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pre-Exposure Prophylaxis Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pre-Exposure Prophylaxis Market Size by Type
  2. 12.1.1 SAMEA Pre-Exposure Prophylaxis Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pre-Exposure Prophylaxis Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pre-Exposure Prophylaxis Price by Type (2021-2032)
  5. 12.2 SAMEA Pre-Exposure Prophylaxis Market Size by Application
  6. 12.2.1 SAMEA Pre-Exposure Prophylaxis Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pre-Exposure Prophylaxis Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pre-Exposure Prophylaxis Price by Application (2021-2032)
  9. 12.3 SAMEA Pre-Exposure Prophylaxis Market Size by Country
  10. 12.3.1 SAMEA Pre-Exposure Prophylaxis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pre-Exposure Prophylaxis Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pre-Exposure Prophylaxis Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pre-Exposure Prophylaxis Value Chain Analysis
  2. 13.1.1 Pre-Exposure Prophylaxis Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pre-Exposure Prophylaxis Production Mode & Process
  6. 13.2 Pre-Exposure Prophylaxis Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pre-Exposure Prophylaxis Distributors
  9. 13.2.3 Pre-Exposure Prophylaxis Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst